Biomarkers will revolutionize the way we diagnose and treat Alzheimer's disease.

摘要

There are more than 60 causes of dementia but the most common form of dementia is Alzheimer's disease (AD), which affects more than 30 million people worldwide [101]. The incidence of AD increases with age: 5% of those over 65 years have the disease but this increases dramatically so that over 30% of individuals aged 85 years and older develop AD. The rate of AD is also higher in women than men in all age groups [102]. It has been estimated that the number of people with AD will be over 100 million by 2050, unless we are able to treat or prevent the disease.